Merus to Present at the 2020 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

Merus (Nasdaq: MRUS), a clinical-stage oncology company, announced that its President and CEO, Bill Lundberg, M.D., will present a company overview at the 2020 Wedbush PacGrow Healthcare Conference. The presentation is scheduled for August 12, 2020, at 10:20 a.m. ET.

A live webcast will be available on the company's website, along with an archived presentation for a limited time.

Merus specializes in developing innovative full-length multispecific antibodies, known as Biclonics® and Triclonics™.

UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics^® and Triclonics™), today announced that Bill Lundberg, M.D., President and Chief Executive Officer, will present a company overview at the 2020 Wedbush PacGrow Healthcare Conference on Wednesday, August 12, 2020 at 10:20 a.m. ET.

A live webcast of the presentation will be available on the Investors page of the Company's website, http://www.merus.nl. An archived presentation will be available on the Merus website for a limited time.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics^®. Multiclonics^® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website, www.merus.nl and https://twitter.com/MerusNV.

Merus Investor and Media Inquiries:
Jillian Connell
Merus N.V.
Investor Relations and Corporate Communications
617-955-4716

FAQ

When is Merus presenting at the Wedbush PacGrow Healthcare Conference?

Merus is presenting on August 12, 2020, at 10:20 a.m. ET.

Who is presenting for Merus at the conference?

Bill Lundberg, M.D., President and CEO of Merus, will present at the conference.

Where can I watch the Merus presentation live?

The live webcast will be available on Merus' Investors page at their website.

What is the stock symbol for Merus?

The stock symbol for Merus is MRUS.

What type of therapeutics does Merus develop?

Merus develops innovative full-length multispecific antibodies known as Biclonics® and Triclonics™.